Compare Abbott Laboratories (ABT) vs ASML Holding NV (ASML) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs ASML Holding NV — how do they compare? Abbott Laboratories trades at $95.15 (market cap $166.94B), while ASML Holding NV trades at $1,772.5 (market cap $662.67B). The key difference: ASML Holding NV is far larger — about 4× Abbott Laboratories's market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | ASML | |
|---|---|---|
Market Cap | $166.94B | $662.67B |
Sector | Health | Technology |
52-Week High | $136.62 | $1.99K |
52-Week Low | $82.57 | $689.63 |
Enterprise Value | $193.69B | $656.21B |
Dividend Yield | 2.63% | 0.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
ASML trades at $1,747.28, down 1.25% amid semiconductor sector volatility. The stock shows strong fundamentals with 2025 revenue of $32.67B and net income of $9.61B, supported by robust profitability margins. Technical indicators are neutral, with support near $1,748. Recent news highlights AI-driven demand and geopolitical risks in chip supply chains.
Outlook remains positive given ASML's monopoly in EUV lithography and analyst consensus price target of $2,210. Risks include cyclical semiconductor demand and geopolitical tensions. Earnings beat in Q1 2026 reinforces growth trajectory, but high valuations require careful monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About ASML Holding NV
Founded in 1984 and based in the Netherlands, ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photomask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a meaningful portion of the cost of making cutting-edge chips. Chipmakers require next-generation EUV lithography tools from ASML to continue past the 5-nanometer process node. ASML's products are used at every major semiconductor manufacturer, including Intel, Samsung, and TSMC.
Read more on ASML →
